Dongwei Jia

725 total citations
23 papers, 584 citations indexed

About

Dongwei Jia is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Dongwei Jia has authored 23 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Dongwei Jia's work include Liver physiology and pathology (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Dongwei Jia is often cited by papers focused on Liver physiology and pathology (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Dongwei Jia collaborates with scholars based in China. Dongwei Jia's co-authors include Jianxin Gu, Peike Peng, Yuanyuan Ruan, Fangfang Duan, Lan Wang, Weicheng Wu, Weibin Wu, Shushu Song, Xiaomin Peng and Bo Zhu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Dongwei Jia

23 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dongwei Jia China 15 344 136 133 124 104 23 584
Ki Cheong Park South Korea 16 360 1.0× 114 0.8× 113 0.8× 190 1.5× 93 0.9× 36 666
Yang Cheng China 14 331 1.0× 206 1.5× 144 1.1× 63 0.5× 64 0.6× 36 606
Huailong Xu China 14 398 1.2× 107 0.8× 134 1.0× 158 1.3× 146 1.4× 17 658
Yunjin Zang China 18 405 1.2× 298 2.2× 123 0.9× 147 1.2× 65 0.6× 50 760
Wen-Chi Feng Taiwan 7 371 1.1× 144 1.1× 127 1.0× 115 0.9× 52 0.5× 9 597
Jonathan Schwank United States 2 253 0.7× 164 1.2× 144 1.1× 142 1.1× 61 0.6× 2 540
Xundi Xu China 13 424 1.2× 206 1.5× 63 0.5× 130 1.0× 48 0.5× 31 718
Jichao Wei China 12 300 0.9× 179 1.3× 53 0.4× 121 1.0× 44 0.4× 22 557

Countries citing papers authored by Dongwei Jia

Since Specialization
Citations

This map shows the geographic impact of Dongwei Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongwei Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongwei Jia more than expected).

Fields of papers citing papers by Dongwei Jia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongwei Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongwei Jia. The network helps show where Dongwei Jia may publish in the future.

Co-authorship network of co-authors of Dongwei Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Dongwei Jia. A scholar is included among the top collaborators of Dongwei Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongwei Jia. Dongwei Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shao, Miaomiao, Dongwei Jia, Wenli Lü, et al.. (2025). Calceolarioside B targets MMP12 in the tumor microenvironment to inhibit M2 macrophage polarization and suppress hepatocellular carcinoma progression. Phytomedicine. 142. 156805–156805. 2 indexed citations
2.
Liang, J. K., Yingyi Zhang, Chengjie Yu, et al.. (2024). Bioinformatics insights into the role of GFPT1 in breast invasive carcinoma: implications for tumor prognosis, immune modulation, and therapeutic applications. Frontiers in Genetics. 15. 1482929–1482929. 1 indexed citations
3.
Li, Mingzhe, Fangfang Duan, Zhiqiang Pan, et al.. (2023). Astragalus Polysaccharide Promotes Doxorubicin-Induced Apoptosis by Reducing O-GlcNAcylation in Hepatocellular Carcinoma. Cells. 12(6). 866–866. 24 indexed citations
4.
Jia, Dongwei, et al.. (2022). α-Hederin inhibits the platelet activating factor-induced metastasis of HCC cells through disruption of PAF/PTAFR axis cascaded STAT3/MMP-2 expression. Pharmacological Research. 178. 106180–106180. 21 indexed citations
5.
6.
Yang, Tao, et al.. (2018). Akebia trifoliata (Thunb.) Koidz Seed Extract inhibits human hepatocellular carcinoma cell migration and invasion in vitro. Journal of Ethnopharmacology. 234. 204–215. 17 indexed citations
7.
Duan, Fangfang, Hao Wu, Dongwei Jia, et al.. (2018). O-GlcNAcylation of RACK1 promotes hepatocellular carcinogenesis. Journal of Hepatology. 68(6). 1191–1202. 82 indexed citations
8.
Li, Lili, Miaomiao Shao, Peike Peng, et al.. (2017). High expression of GFAT1 predicts unfavorable prognosis in patients with hepatocellular carcinoma. Oncotarget. 8(12). 19205–19217. 38 indexed citations
9.
Peng, Peike, Weicheng Wu, Junjie Zhao, et al.. (2016). Decreased expression of Calpain-9 predicts unfavorable prognosis in patients with gastric cancer. Scientific Reports. 6(1). 29604–29604. 23 indexed citations
10.
Yang, Caiting, Peike Peng, Lili Li, et al.. (2016). High expression of GFAT1 predicts poor prognosis in patients with pancreatic cancer. Scientific Reports. 6(1). 39044–39044. 53 indexed citations
11.
Shao, Miaomiao, Lili Li, Shushu Song, et al.. (2016). E3 ubiquitin ligase CHIP interacts with C-type lectin-like receptor CLEC-2 and promotes its ubiquitin-proteasome degradation. Cellular Signalling. 28(10). 1530–1536. 9 indexed citations
12.
Wang, Jiajun, Miaomiao Shao, Min Liu, et al.. (2015). PKCα promotes generation of reactive oxygen species via DUOX2 in hepatocellular carcinoma. Biochemical and Biophysical Research Communications. 463(4). 839–845. 14 indexed citations
13.
Liu, Min, Peike Peng, Jiajun Wang, et al.. (2015). RACK1-mediated translation control promotes liver fibrogenesis. Biochemical and Biophysical Research Communications. 463(3). 255–261. 12 indexed citations
14.
Jia, Dongwei, Fangfang Duan, Peike Peng, et al.. (2015). Pyrroloquinoline-Quinone Suppresses Liver Fibrogenesis in Mice. PLoS ONE. 10(3). e0121939–e0121939. 27 indexed citations
15.
Wu, Weibin, Bo Zhu, Xiaomin Peng, et al.. (2013). Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease. Biochemical and Biophysical Research Communications. 443(1). 68–73. 97 indexed citations
16.
Jia, Dongwei, Peike Peng, Linlin Sun, et al.. (2013). Up-Regulation of RACK1 by TGF-β1 Promotes Hepatic Fibrosis in Mice. PLoS ONE. 8(3). e60115–e60115. 30 indexed citations
17.
Wang, Lijing, Dongwei Jia, Zhichao Sun, et al.. (2012). Combined anti-tumor effects of IFN-α and sorafenib on hepatocellular carcinoma in vitro and in vivo. Biochemical and Biophysical Research Communications. 422(4). 687–692. 26 indexed citations
18.
Chen, Hong, Yuqing Hao, Lijing Wang, et al.. (2012). Sodium arsenite down-regulates the expression of X-linked inhibitor of apoptosis protein via translational and post-translational mechanisms in hepatocellular carcinoma. Biochemical and Biophysical Research Communications. 422(4). 721–726. 9 indexed citations
19.
Sun, Zhichao, Weibin Wu, Dongwei Jia, et al.. (2012). Fibroblast growth factor 7 inhibits cholesterol 7α-hydroxylase gene expression in hepatocytes. Biochemical and Biophysical Research Communications. 423(4). 775–780. 14 indexed citations
20.
Wang, Xiaoling, Dongwei Jia, Xudong Hu, et al.. (2012). Effect of Yiguanjian decoction on cell differentiation and proliferation in CCl₄-treated mice.. PubMed. 18(25). 3235–49. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026